We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.81B
AUM Growth
+$240M
(+15%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
11.48%
Top 10 Holdings %
Top 10 Hldgs %
3.88%
Holding
2,105
New
481
Increased
671
Reduced
539
Closed
400
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$9.12M |
| 2 |
Visa
V
|
+$8.75M |
| 3 |
Motorola Solutions
MSI
|
+$7.37M |
| 4 |
Edwards Lifesciences
EW
|
+$7.3M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$4.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.1M |
| 2 |
Bausch Health
BHC
|
+$5.94M |
| 3 |
Deere & Co
DE
|
+$5.72M |
| 4 |
Constellation Brands
STZ
|
+$4.59M |
| 5 |
Qualcomm
QCOM
|
+$4.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.07% |
| 2 | Industrials | 13.48% |
| 3 | Consumer Discretionary | 12.62% |
| 4 | Technology | 11.4% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MANT
826
DELISTED
Mantech International Corp
MANT
| $750K | 0.04% |
+19,831
| New | +$680K |
|
|
SRDX
827
DELISTED
Surmodics
SRDX
| $748K | 0.04% |
31,840
-23,969
| -43% | -$525K |
|
828
Core Molding Technologies
CMT
$202M
| $747K | 0.04% |
54,710
-29,700
| -35% | -$367K |
|
829
Texas Pacific Land
TPL
$27.8B
| $744K | 0.04% |
+39,681
| New | +$703K |
|
|
IBTX
830
DELISTED
Independent Bank Group, Inc.
IBTX
| $743K | 0.04% |
17,326
-9,127
| -35% | -$325K |
|
|
LMRK
831
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $741K | 0.04% |
45,023
-300
| -0.7% | -$4.66K |
|
|
RDC
832
DELISTED
Rowan Companies Plc
RDC
| $739K | 0.04% |
41,873
+12,916
| +45% | +$224K |
|
833
Casella Waste Systems
CWST
$5.71B
| $738K | 0.04% |
93,974
+74,876
| +392% | +$537K |
|
834
MasterCraft Boat Holdings
MCFT
$579M
| $738K | 0.04% |
66,768
+23,000
| +53% | +$302K |
|
835
Addus HomeCare
ADUS
$2.16B
| $734K | 0.04% |
42,100
+9,100
| +28% | +$173K |
|
|
HBI
836
DELISTED
Hanesbrands
HBI
| $734K | 0.04% |
29,227
+3,914
| +15% | +$107K |
|
|
AVID
837
DELISTED
Avid Technology Inc
AVID
| $733K | 0.04% |
126,247
-22,700
| -15% | -$134K |
|
|
LPT
838
DELISTED
Liberty Property Trust
LPT
| $732K | 0.04% |
+18,428
| New | +$670K |
|
|
DCP
839
DELISTED
DCP Midstream, LP
DCP
| $731K | 0.04% |
21,183
+8,743
| +70% | +$287K |
|
840
KLA
KLAC
$239B
| $729K | 0.04% |
+99,500
| New | +$713K |
|
|
SINA
841
DELISTED
Sina Corp
SINA
| $729K | 0.04% |
+14,047
| New | +$702K |
|
|
ARRS
842
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $728K | 0.04% |
34,740
+19,785
| +132% | +$449K |
|
|
STOR
843
DELISTED
STORE Capital Corporation
STOR
| $727K | 0.04% |
24,700
-16,656
| -40% | -$439K |
|
|
MLNX
844
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $727K | 0.04% |
15,163
+943
| +7% | +$44.8K |
|
845
Park Aerospace
PKE
$737M
| $726K | 0.04% |
50,000
-5,700
| -10% | -$90.2K |
|
|
NUTR
846
DELISTED
Nutraceutical International Co
NUTR
| $726K | 0.04% |
31,381
-9,262
| -23% | -$220K |
|
847
AllianceBernstein
AB
$3.43B
| $722K | 0.04% |
31,000
+4,100
| +15% | +$95.6K |
|
|
NCIT
848
DELISTED
NCI, Inc.
NCIT
| $722K | 0.04% |
51,420
-7,026
| -12% | -$96.8K |
|
849
HCI Group
HCI
$2.23B
| $718K | 0.04% |
26,308
+8,225
| +45% | +$253K |
|
|
LJPC
850
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $718K | 0.04% |
44,900
+22,400
| +100% | +$402K |
|
Similar funds
ACB
SCI
SCM
BW
HH
KCM
PRA
CC
GSA Capital Partners's Q2 2016 Portfolio in Review
As of Q2 2016, GSA Capital Partners held 2,105 positions worth $1.81B, up 15% from $1.57B the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.
GSA Capital Partners deployed $208M of net new capital in Q2 2016, opening 481 new positions and adding to 671 existing holdings. Its largest new stake was Mastercard: 95,471 shares worth $8.41M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Bausch Health, an estimated $5.94M trimmed.
- GSA Capital Partners's largest Q2 2016 buy was Mastercard: 95,471 shares worth $8.41M.
- GSA Capital Partners added most to Motorola Solutions in Q2 2016, an estimated $7.37M increase.
- GSA Capital Partners's biggest Q2 2016 reduction was Bausch Health, cutting an estimated $5.94M.
- GSA Capital Partners fully exited Allergan plc in Q2 2016, selling an estimated $6.1M.
- GSA Capital Partners's ten largest holdings make up 3.9% of its $1.81B portfolio in Q2 2016.
- GSA Capital Partners opened 481 new positions and closed 400 in Q2 2016.
- GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.81B.
Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.